Trial intelligence / Profile preview

Decitabine in Imatinib-Refractory CML Blast Phase

NCT00042003Phase 2Completed

Sponsor
Astex Pharmaceuticals
Start
Jul 2002
Primary completion
Dec 2004
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of decitabine, sponsored by Astex Pharmaceuticals. Started Jul 2002; status: completed.

02

Drugs

decitabine

Beyond the preview

Go deeper on NCT00042003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00042003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call